Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-006340
Filing Date
2018-01-31
Accepted
2018-01-31 20:12:17
Documents
2
Period of Report
2018-01-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6290
2 POA DOCUMENT poa.txt EX-24.4_765220 3673
  Complete submission text file 0001209191-18-006340.txt   11452
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Issuer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 721 ST. GEORGES ROAD PHILADELPHIA PA 19119
Business Address
Macrae Sandy (Reporting) CIK: 0001675687 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30171 | Film No.: 18564310